Current Topics in Medicinal Chemistry

Editor-in-Chief:

Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc.
Doylestown, PA
USA

Back

Become EABM
Become Reviewer

Editorial [Hot topic: Parkinsons Disease (Guest Editor: Jurgen Dinges)] promotion: free to download

Volume:9   Issue:10
Pp: 854-854
Jurgen Dinges
DOI: 10.2174/156802609789378290

Etiopathogenesis and Treatment of Parkinsons Disease

Volume:9   Issue:10
Pp: 860-868
David A. Gallagher and Anthony H. V. Schapira
DOI: 10.2174/156802609789378227

The Role of Autophagy on the Survival of Dopamine Neurons

Volume:9   Issue:10
Pp: 869-879
Ciro Isidoro, Francesca Biagioni, Filippo Sean Giorgi, Federica Fulceri, Antonio Paparelli and Francesco Fornai
DOI: 10.2174/156802609789378281

Half a Century of l-DOPA

Volume:9   Issue:10
Pp: 880-893
Maria Angeles Mena, Maria Jose Casarejos, Rosa Maria Solano and Justo Garcia de Yebenes
DOI: 10.2174/156802609789378263

Behavioural Sensitisation During Dopamine Replacement Therapy in Parkinsons Disease is Reminiscent of the Addicted Brain

Volume:9   Issue:10
Pp: 894-902
F. Biagioni, A. Pellegrini, S. Ruggieri, L. Murri, A. Paparelli and F. Fornai1
DOI: 10.2174/156802609789378245

Cognitive Impairment and Dementia in Patients with Parkinson Disease

Volume:9   Issue:10
Pp: 903-912
James B. Leverenz, Joseph F. Quinn, Cyrus Zabetian, Jing Zhang, Kathleen S. Montine and Thomas J. Montine
DOI: 10.2174/156802609789378218

New Molecular Avenues in Parkinson ’ s Disease Therapy

Volume:9   Issue:10
Pp: 913-948
Mario Di Napoli
DOI: 10.2174/156802609789378254

Recent Progress in the Development of mGluR4 Positive Allosteric Modulators for the Treatment of Parkinsons Disease

Volume:9   Issue:10
Pp: 949-963
Craig W. Lindsley, Colleen M. Niswender, Darren W. Engers and Corey R. Hopkins
DOI: 10.2174/156802609789378272